# Integrative Analysis of Post-Translational Modifications Identifies a PTM-Enriched Regulatory Core in Human Metabolic Enzymes

**Authors:** Susmi Varghese, Sreelakshmi Pathappillil Soman, Mukhtar Ahmed, Levin John, Poornima Ramesh, Sowmya Soman, Vinitha Ramanath Pai, Rajesh Raju

PMC · DOI: 10.3390/metabo16030163 · 2026-02-28

## TL;DR

This study maps how post-translational modifications regulate human metabolic enzymes, revealing a core group of enzymes with dense regulatory modifications.

## Contribution

The paper introduces a systems-level framework for analyzing multiple PTMs across metabolic enzymes, identifying a regulatory core with high PTM density.

## Key findings

- PTMs are unevenly distributed, with phosphorylation, acetylation, ubiquitination, and methylation being the most common.
- A PTM-enriched regulatory group includes rate-limiting enzymes with frequent hotspot regions and crosstalk.
- The regulatory core forms a discrete subnetwork in central metabolic pathways.

## Abstract

Background: Metabolic enzymes catalyze biochemical pathways that sustain cellular metabolism. Their activity, stability, and molecular interactions are extensively regulated by post-translational modifications (PTMs). However, an integrated systems-level understanding of how diverse PTMs are organized across the human metabolic network remains poorly defined. Methods: We integrated experimentally reported PTM annotations from PhosphoSitePlus, dbPTM, and the quantitative PTM database (qPTM), and identified 29 distinct PTM types present across the 771 human metabolic enzymes. PTM features were quantitatively characterized at multiple levels, including sequence- and composition-based metrics (modification density and PTM potentiality rate), recurrence- and co-occurrence-based features (predominant sites, hotspot regions and PTM crosstalk), and functional-context annotations (protein-region localization and mutation overlap). These integrated features were subsequently used for unsupervised clustering to evaluate higher-order organizational patterns. Results: The analysis revealed that PTMs are unevenly distributed across metabolic enzymes, with phosphorylation, acetylation, ubiquitination, and methylation representing the most prevalent and recurrent regulatory modifications. Clustering segregated enzymes into two regulatory groups: (i) a PTM-enriched regulatory group characterized by high PTM density, frequent hotspot and crosstalk regions, and enrichment of rate-limiting enzymes, and (ii) a broad metabolic group with comparatively sparse PTM regulation. This non-uniform organization reflects the preferential accumulation of multiple regulatory PTMs on enzymes occupying key control points in central metabolic pathways, thereby forming a discrete regulatory subnetwork within metabolism. Conclusions: This study presents a systems-level, multi-PTM atlas of human metabolic enzymes and provides a quantitative framework for prioritizing PTM-regulated enzymes and pathways relevant to signaling–metabolism integration and disease-associated metabolic regulation.

## Full-text entities

- **Genes:** TRIM21 (tripartite motif containing 21) [NCBI Gene 6737] {aka RNF81, RO52, Ro/SSA, SSA, SSA1, TRIM21/Ro52}, FH (fumarate hydratase) [NCBI Gene 2271] {aka FMRD, HLRCC, HsFH, LRCC, MCL, MCUL1}, G6PD (glucose-6-phosphate dehydrogenase) [NCBI Gene 2539] {aka CNSHA1, G6PD1}, PRMT5 (protein arginine methyltransferase 5) [NCBI Gene 10419] {aka HRMT1L5, HSL7, IBP72, JBP1, SKB1, SKB1Hs}, HK1 (hexokinase 1) [NCBI Gene 3098] {aka CNSHA5, HK, HK1-ta, HK1-tb, HK1-tc, HKD}, ACO2 (aconitase 2) [NCBI Gene 50] {aka ACONM, HEL-S-284, ICRD, OCA8, OPA9}, PLB1 (phospholipase B1) [NCBI Gene 151056] {aka PLB, PLB/LIP}, ALDOA (aldolase, fructose-bisphosphate A) [NCBI Gene 226] {aka ALDA, GSD12, HEL-S-87p}, PDK1 (pyruvate dehydrogenase kinase 1) [NCBI Gene 5163], MCEE (methylmalonyl-CoA epimerase) [NCBI Gene 84693] {aka GLOD2, MCE, MMCE}, PKLR (pyruvate kinase L/R) [NCBI Gene 5313] {aka CNSHA2, PK1, PKL, PKRL, RPK}, DHFR (dihydrofolate reductase) [NCBI Gene 1719] {aka DHFR1, DYR}, PHGDH (phosphoglycerate dehydrogenase) [NCBI Gene 26227] {aka 3-PGDH, 3PGDH, HEL-S-113, NLS, NLS1, PDG}, ACACA (acetyl-CoA carboxylase alpha) [NCBI Gene 31] {aka ACAC, ACACAD, ACACalpha, ACC, ACC1, ACCA}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, LIPT2 (lipoyl(octanoyl) transferase 2) [NCBI Gene 387787], TPI1 (triosephosphate isomerase 1) [NCBI Gene 7167] {aka HEL-S-49, TIM, TPI, TPID}, HMGCS1 (3-hydroxy-3-methylglutaryl-CoA synthase 1) [NCBI Gene 3157] {aka CMYO28, HMGCS}, MDH2 (malate dehydrogenase 2) [NCBI Gene 4191] {aka DEE51, EIEE51, M-MDH, MDH, MGC:3559, MOR1}, CPS1 (carbamoyl-phosphate synthase 1) [NCBI Gene 1373] {aka CPS1D, CPSASE1, GATD6, PHN}, HMGCS2 (3-hydroxy-3-methylglutaryl-CoA synthase 2) [NCBI Gene 3158], DLST (dihydrolipoamide S-succinyltransferase) [NCBI Gene 1743] {aka DLTS, KGD2, PGL7, PPGL7}, PKM (pyruvate kinase M1/2) [NCBI Gene 5315] {aka CTHBP, HEL-S-30, OIP3, PK3, PKM2, TCB}, PDP1 (pyruvate dehydrogenase phosphatase catalytic subunit 1) [NCBI Gene 54704] {aka PDH, PDP, PDPC, PDPC 1, PPM2A, PPM2C}, PDHA1 (pyruvate dehydrogenase E1 subunit alpha 1) [NCBI Gene 5160] {aka E1alpha, PDHA, PDHAD, PDHCE1A, PHE1A}, FASN (fatty acid synthase) [NCBI Gene 2194] {aka FAS, OA-519, SDR27X1}, ACAA1 (acetyl-CoA acyltransferase 1) [NCBI Gene 30] {aka ACAA, Lnc-Myd88, PTHIO, THIO}, OGDHL (oxoglutarate dehydrogenase L) [NCBI Gene 55753] {aka YOBELN}, PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta) [NCBI Gene 5291] {aka P110BETA, PI3K, PI3KBETA, PIK3C1}, TPH1 (tryptophan hydroxylase 1) [NCBI Gene 7166] {aka TPRH, TRPH}, OGDH (oxoglutarate dehydrogenase) [NCBI Gene 4967] {aka AKGDH, E1k, E1o, HsOGDH, KGD1, OGDC}, GAPDH (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 2597] {aka G3PD, GAPD, HEL-S-162eP}, ACO1 (aconitase 1) [NCBI Gene 48] {aka ACONS, HEL60, IREB1, IREBP, IREBP1, IRP1}, SYVN1 (synoviolin 1) [NCBI Gene 84447] {aka DER3, HRD1}, NR0B2 (nuclear receptor subfamily 0 group B member 2) [NCBI Gene 8431] {aka SHP, SHP1}, ACLY (ATP citrate lyase) [NCBI Gene 47] {aka ACL, ATPCL, CLATP}, HYAL3 (hyaluronidase 3) [NCBI Gene 8372] {aka HYAL-3, LUCA-3, LUCA3}, TPH2 (tryptophan hydroxylase 2) [NCBI Gene 121278] {aka ADHD7, NTPH}, HK2 (hexokinase 2) [NCBI Gene 3099] {aka HKII, HXK2}, DNMT1 (DNA methyltransferase 1) [NCBI Gene 1786] {aka ADCADN, AIM, CXXC9, DNMT, HSN1E, MCMT}, PFKM (phosphofructokinase, muscle) [NCBI Gene 5213] {aka ATP-PFK, GSD7, PFK-1, PFK-A, PFK1, PFKA}, MTOR (mechanistic target of rapamycin kinase) [NCBI Gene 2475] {aka FRAP, FRAP1, FRAP2, RAFT1, RAPT1, SKS}
- **Diseases:** diabetes (MESH:D003920), PTM (OMIM:614922), N-linked glycosylation (MESH:C536108), cardiovascular disease (MESH:D002318), prostate cancer (MESH:D011471), non-alcoholic fatty liver disease (MESH:D065626), O-linked glycosylation (MESH:C535508), injury to (MESH:D014947), breast cancer (MESH:D001943), inherited metabolic disorders (MESH:D020739), metabolic syndrome (MESH:D024821), glioblastoma (MESH:D005909), hypoxia (MESH:D000860), PDHc deficiency (MESH:D015325), cancer (MESH:D009369), metabolic disease (MESH:D008659)
- **Chemicals:** ADP (MESH:D000244), fumarate (MESH:D005650), pentose phosphate (MESH:D010428), lipid (MESH:D008055), NADPH (MESH:D009249), ketone body (MESH:D007657), fatty acid (MESH:D005227), TCA (MESH:D014233), carbon (MESH:D002244), acid (MESH:D000143), citrate (MESH:D019343), L-malate (-), GPI (MESH:D017261), malate (MESH:C030298), tyrosine (MESH:D014443), melatonin (MESH:D008550), nucleotide (MESH:D009711), pyruvate (MESH:D019289), amino-acid (MESH:D000596), cysteine (MESH:D003545)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Mutations:** Serine/Threonine, S293A

## Figures

11 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13027432/full.md

---
Source: https://tomesphere.com/paper/PMC13027432